# Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients

> **NCT01363193** · NA · UNKNOWN · sponsor: **Nazareth Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Obesity
- Morbid Obesity
- Venous Thromboembolism
- Atrial Fibrillation
- Angina
- Chest Pain

## Interventions

- **DRUG:** Lean Body Weight-based heparin dose

## Key facts

- **NCT ID:** NCT01363193
- **Lead sponsor:** Nazareth Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01363193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01363193, "Safety and Efficacy of Lean Body Weight-based IV Heparin Dosing in Obese/Morbidly Obese Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01363193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*